The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome

Published 2011 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 18, Pages 4963-4966
Publisher
American Society of Hematology
Online
2011-08-12
DOI
10.1182/blood-2011-06-360586
References
View 2 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.